<!doctype html>
<html lang="es">
<head>
<meta charset="utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<title>Spanish Daily – Nov 18, 2025</title>
<meta name="color-scheme" content="light dark" />
<style>
  :root { --maxw: 800px; }
  html { -webkit-text-size-adjust: 100%; }
  body { margin: 0; padding: 0; font-family: system-ui,-apple-system,Segoe UI,Roboto,Helvetica,Arial,sans-serif,Apple Color Emoji,Segoe UI Emoji; line-height: 1.6; font-size: 18px; }
  header, main, footer { max-width: var(--maxw); margin: 0 auto; padding: 16px; }
  header { padding-top: 20px; }
  h1 { font-size: 1.4rem; margin: 0 0 8px; }
  .subtle { opacity: 0.72; font-size: 0.95rem; }
  .card { border: 1px solid rgba(0,0,0,0.08); border-radius: 12px; padding: 14px; margin: 12px 0; }
  .tip-word { all: unset; display: inline; position: relative; cursor: pointer;
    text-decoration: underline dotted; text-underline-offset: 3px;
    padding: 0 .1em; border-radius: .35em; background: rgba(255,235,59,.28); }
  .tooltip { position: fixed; padding: .48rem .6rem; background: rgba(0,0,0,.88); color: #fff;
    border-radius: .55rem; font-size: .95rem; line-height: 1.3; max-width: min(90vw, 26rem);
    z-index: 9999; box-shadow: 0 6px 18px rgba(0,0,0,.18); }
  .content { white-space: pre-line; }
  .card { margin-bottom: 1.5em; line-height: 1.6; }
  strong { display: inline-block; margin-top: .35em; }
  details { border: 1px solid rgba(0,0,0,0.08); border-radius: 12px; padding: 12px; }
  details + details, details + .card { margin-top: 12px; }
  summary { cursor: pointer; font-weight: 600; }
  summary::marker { content: ""; }
  summary::after { content: " ▸"; }
  details[open] summary::after { content: " ▾"; }
  .debug { position: fixed; bottom: 8px; right: 8px; font-size: 12px; opacity: .6; }
</style>
</head>
<body>
  <header>
    <h1>Spanish Daily</h1>
    <div class="subtle">Toca una palabra subrayada para ver la traducción. Toca fuera para cerrar.</div>
  </header>

  <main>
    <!-- Spanish first -->
    <section class="card content">
STORY

<span title="Kidney">La enfermedad renal</span> se observa con frecuencia en personas con <span title="diabetes">diabetes</span>. Es importante detectarla temprano. Una forma de hacerlo es mediante la prueba de <span title="albuminuria (protein in urine)">albuminuria</span>, que es un signo de daño renal. Los médicos deben realizar esta prueba cada año en personas con <span title="diabetes">diabetes</span>. Si se detecta <span title="albuminuria (protein in urine)">albuminuria</span> de manera temprana, los médicos pueden iniciar un tratamiento para retrasar el avance de la <span title="kidney disease">enfermedad renal</span>. Un tratamiento consiste en usar medicamentos llamados <span title="SGLT2 inhibitors">inhibidores de SGLT2</span>, como <span title="empagliflozin">empagliflozina</span> y <span title="dapagliflozin">dapagliflozina</span>. Estos medicamentos ayudan a proteger los <span title="kidneys">riñones</span> en personas con <span title="type 2 diabetes">diabetes tipo 2</span> y <span title="kidney disease">enfermedad renal</span>. También ayudan a bajar el <span title="blood sugar">azúcar en la sangre</span> y a evitar que la <span title="kidney disease">enfermedad renal</span> empeore. Además, pueden reducir el riesgo de problemas <span title="heart">cardíacos</span>. Sin embargo, los médicos deben vigilar posibles efectos secundarios como <span title="infections">infecciones</span> y <span title="dehydration">deshidratación</span>. Las nuevas guías <span title="KDIGO">KDIGO</span> 2022 recomiendan considerar el uso temprano de <span title="SGLT2 inhibitors">inhibidores de SGLT2</span> en el tratamiento de la <span title="diabetes">diabetes</span>, especialmente si hay signos de daño renal. Por eso, hacer la prueba de <span title="albuminuria (protein in urine)">albuminuria</span> a tiempo y usar <span title="SGLT2 inhibitors">inhibidores de SGLT2</span> puede ayudar a las personas con <span title="diabetes">diabetes</span> y <span title="kidney disease">enfermedad renal</span>.

---
DIALOGUE

Narrator: Hoy vemos a un médico hablando con un paciente con <span title="diabetes">diabetes</span> sobre la salud <span title="kidney">renal</span>.
Physician: Hola. Quiero revisar sus <span title="kidneys">riñones</span>. La <span title="diabetes">diabetes</span> puede dañar los <span title="kidneys">riñones</span>.
Patient: No lo sabía. ¿Cómo revisa mis <span title="kidneys">riñones</span>?
Physician: Usamos una prueba de orina para buscar <span title="albuminuria (protein in urine)">albuminuria</span>. Eso significa <span title="protein">proteína</span> en la orina.
Patient: ¿La <span title="albuminuria (protein in urine)">albuminuria</span> es mala?
Physician: Sí. Si la detectamos temprano, podemos retrasar la <span title="kidney disease">enfermedad renal</span>.
Patient: ¿Qué puede ayudar a mis <span title="kidneys">riñones</span> si tengo <span title="albuminuria (protein in urine)">albuminuria</span>?
Physician: Hay un medicamento llamado <span title="SGLT2 inhibitor">inhibidor de SGLT2</span>, como <span title="empagliflozin">empagliflozina</span> o <span title="dapagliflozin">dapagliflozina</span>.
Patient: ¿Qué hace este medicamento?
Physician: Ayuda a proteger los <span title="kidneys">riñones</span>. También puede bajar el <span title="blood sugar">azúcar en la sangre</span> y ayudar a su <span title="heart">corazón</span>.
Patient: ¿Hay problemas con este medicamento?
Physician: A veces puede haber <span title="infections">infecciones</span> o <span title="dehydration">deshidratación</span>. Vamos a estar atentos a eso.
Patient: ¿Debo empezar este medicamento pronto?
Physician: Sí, las nuevas guías dicen que se debe iniciar temprano si vemos daño <span title="kidney">renal</span>.
Patient: Gracias. Quiero cuidar mis <span title="kidneys">riñones</span>.

    </section>

    <!-- English below -->

    <details open class="card content">
      <summary>INGLÉS</summary>
STORY

Kidney disease is often seen in people with diabetes. It is important to catch it early. One way to do this is to test for albuminuria, a sign of kidney damage. Doctors should do this test every year for people with diabetes. If albuminuria is found early, doctors can start treatment to slow down kidney disease. One treatment is using drugs called SGLT2 inhibitors, like empagliflozin and dapagliflozin. These drugs help protect the kidneys in people with type 2 diabetes and kidney disease. They also help lower blood sugar and stop kidney disease from getting worse. They can also lower the risk of heart problems. But doctors need to watch for side effects like infections and low body water. The new 2022 KDIGO rules say to think about using SGLT2 inhibitors early in treating diabetes, especially if there are signs of kidney damage. So, doing the albuminuria test early and using SGLT2 inhibitors can help people with diabetes and kidney disease.

---
DIALOGUE

Narrator: Today, we see a doctor talking to a patient with diabetes about kidney health.
Physician: Hello. I want to check your kidneys. Diabetes can hurt the kidneys.
Patient: I did not know that. How do you check my kidneys?
Physician: We use a urine test to look for albuminuria. That means protein in your urine.
Patient: Is albuminuria bad?
Physician: Yes. If we find it early, we can slow kidney disease.
Patient: What can help my kidneys if there is albuminuria?
Physician: There is a medicine called SGLT2 inhibitor, like empagliflozin or dapagliflozin.
Patient: What does this medicine do?
Physician: It helps protect kidneys. It can also lower blood sugar and help your heart.
Patient: Are there problems with this medicine?
Physician: Sometimes there can be infections or low body water. We will watch for that.
Patient: Should I start this medicine soon?
Physician: Yes, the new rules say to start early if we see kidney damage.
Patient: Thank you. I want to take care of my kidneys.
    </details>
  </main>

  <footer class="subtle">
    <div>© Nov 18, 2025 · Mezra.AI · Practica todos los días.</div>
  </footer>

  <div class="debug">EN: found</div>

  <!-- NEW: light cache-busting helper -->
  <script>
  (function() {
    // 1. Get the version tag from the URL, if present (?v=SHA...)
    var params = new URLSearchParams(window.location.search);
    var version = params.get('v');

    // 2. Read the debug indicator already inside your page
    var debug = document.querySelector('.debug');
    var debugText = debug ? debug.textContent.trim() : '';

    // 3. Heuristic: if version is missing or debug looks suspicious, force a one-time reload
    var isLikelyStale =
      !version ||
      debugText === '' ||
      debugText.indexOf('placeholder') !== -1 ||
      debugText.indexOf('not found') !== -1 ||
      debugText.length < 3;

    if (isLikelyStale) {
      if (!params.get('forceReload')) {
        params.set('forceReload', '1');
        var newUrl = window.location.pathname + '?' + params.toString();
        window.location.replace(newUrl);
      }
    }
  })();
  </script>

  <!-- Existing tooltip behavior -->
  <script>
  (function () {
    document.querySelectorAll('.content').forEach(function(container) {
      container.querySelectorAll('span[title]').forEach(function(span) {
        var text = span.textContent;
        var tip  = span.getAttribute('title');
        var btn  = document.createElement('button');
        btn.className = 'tip-word'; btn.type = 'button';
        btn.textContent = text; btn.setAttribute('data-tip', tip);
        span.replaceWith(btn);
      });
    });

    var openTip = null;
    function closeTip(){ if(openTip){ openTip.remove(); openTip = null; } }
    function showTip(target){
      closeTip();
      var tipText = target.getAttribute('data-tip') || '';
      if(!tipText) return;
      var bubble = document.createElement('div');
      bubble.className = 'tooltip';
      bubble.textContent = tipText;
      document.body.appendChild(bubble);
      var r = target.getBoundingClientRect();
      var m = 8, vw = innerWidth, vh = innerHeight;
      var rect = bubble.getBoundingClientRect();
      var tw = rect.width;
      var th = rect.height;
      var left = r.left, top = r.bottom + m;
      if (left + tw + m > vw) left = Math.max(m, vw - tw - m);
      if (left < m) left = m;
      if (top + th + m > vh) top = Math.max(m, r.top - th - m);
      bubble.style.left = left + 'px';
      bubble.style.top  = top + 'px';
      openTip = bubble;
    }

    document.addEventListener('click', function(e) {
      var word = e.target.closest('.tip-word');
      if (word){ if (openTip) closeTip(); else showTip(word); e.stopPropagation(); }
      else { closeTip(); }
    });
    document.addEventListener('touchstart', function(e) {
      if (!e.target.closest('.tip-word')) closeTip();
    }, { passive: true });
    addEventListener('scroll', closeTip, { passive: true });
    addEventListener('resize', closeTip);
    document.addEventListener('keydown', function(e) { if (e.key === 'Escape') closeTip(); });
  })();
  </script>
</body>
</html>